Evidence map›Paper›PMID 28553149›Full record

ArticleMedical devices (Auckland, N.Z.)2017

A multicenter prospective study of patients undergoing open ventral hernia repair with intraperitoneal positioning using the monofilament polyester composite ventral patch: interim results of the PANACEA study.

Frederik Berrevoet, Carl Doerhoff, Filip Muysoms, Steven Hopson, Marco Gallinella Muzi, Simon Nienhuijs, Eric Kullman, Tim Tollens, Mark R Schwartz, Karl LeBlanc and 2 more

Abstract read
In one paragraph

Article in Medical devices (Auckland, N.Z.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Frederik BerrevoetDepartment of General and Hepatopancreaticobiliary Surgery, Ghent University Hospital, Ghent, Belgium.
Carl DoerhoffGeneral Surgery, Surgicare of Missouri, Jefferson City, MO, USA.
Filip MuysomsDepartment of Surgery, AZ Maria Middelares Ghent, Ghent, Belgium.
Steven HopsonBon Secours Hernia Center, Mary Immaculate Hospital, Newport News, VA, USA.
Marco Gallinella MuziUniversity Hospital Tor Vergata, Rome, Italy.
Simon NienhuijsCatharina Hospital, Eindhoven, the Netherlands.
Eric KullmanMedicinskt Centrum Linköping, Linköping, Sweden.
Tim TollensImelda Hospital-General Surgery Imelda Hospital, Bonheiden, Belgium.
Mark R SchwartzMonmouth Medical Center, Long Branch, NJ.
Karl LeBlancOur Lady of Lakes Regional Medical Center, Baton Rouge, LA.
Vic VelanovichTampa General Hospital, University of South Florida, Tampa, FL, USA.
Lars Nannestad JørgensenBispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study assessed the recurrence rate and other safety and efficacy parameters following ventral hernia repair with a polyester composite prosthesis (Parietex™ Composite Ventral Patch [PCO-VP]). PATIENTS AND

methodsA single-arm, multicenter prospective study of 126 patients undergoing open ventral hernia repair with the PCO-VP was performed. Patient outcomes were assessed at discharge and at 10 days, 1, 6, 12, and 24 months postoperative.

resultsAll patients had hernioplasty for umbilical (n = 110, 87.3%) or epigastric hernia (n = 16, 12.7%). Mean hernia diameter was 1.8 ± 0.8 cm. Mean operative time was 36.2 ±15.6 minutes, with a mean mesh positioning time of 8.1 ± 3.4 minutes. Surgeons reported satisfaction with mesh ease of use in 95% of surgeries. The cumulative hernia recurrence rate at 1 year was 2.8% (3/106). Numeric Rating Scale (NRS) pain scores showed improvement from 2.1 ± 2.0 at preoperative baseline to 0.5 ± 0.7 at 1 month postoperative (

conclusionThis 1-year interim analysis using PCO-VP for primary umbilical and epigastric defects shows promising results in terms of mesh ease of use, postoperative pain, and patient satisfaction. Recurrence rate is low, but, as laparoscopic evaluation shows a need for patch repositioning in some cases, an accurate surgical technique remains of utmost importance.

Indexed as

epigastric herniaintraperitoneal meshpainumbilical hernia

Identifiers

PMID28553149
PMCPMC5440003

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.